227 related articles for article (PubMed ID: 12237594)
1. Treatment of cerebrospinal fluid shunt infections: a decision analysis.
Schreffler RT; Schreffler AJ; Wittler RR
Pediatr Infect Dis J; 2002 Jul; 21(7):632-6. PubMed ID: 12237594
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid shunt infections in children.
Turgut M; Alabaz D; Erbey F; Kocabas E; Erman T; Alhan E; Aksaray N
Pediatr Neurosurg; 2005; 41(3):131-6. PubMed ID: 15995329
[TBL] [Abstract][Full Text] [Related]
3. CSF shunt infections: a fifteen-year experience with emphasis on management and outcome.
Morissette I; Gourdeau M; Francoeur J
Can J Neurol Sci; 1993 May; 20(2):118-22. PubMed ID: 8334572
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an institutional guideline for the treatment of cerebrospinal fluid shunt-associated infections.
von der Brelie C; Simon A; Gröner A; Molitor E; Simon M
Acta Neurochir (Wien); 2012 Sep; 154(9):1691-7. PubMed ID: 22454037
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized study of therapy in cerebrospinal fluid shunt infection.
James HE; Walsh JW; Wilson HD; Connor JD; Bean JR; Tibbs PA
Neurosurgery; 1980 Nov; 7(5):459-63. PubMed ID: 7003434
[TBL] [Abstract][Full Text] [Related]
6. Aggressive management of shunt infection: combined intravenous and intraventricular antibiotic therapy for twelve or less days.
James HE; Bradley JS
Pediatr Neurosurg; 2008; 44(2):104-11. PubMed ID: 18230923
[TBL] [Abstract][Full Text] [Related]
7. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts.
Parker SL; Attenello FJ; Sciubba DM; Garces-Ambrossi GL; Ahn E; Weingart J; Carson B; Jallo GI
Childs Nerv Syst; 2009 Jan; 25(1):77-83; discussion 85. PubMed ID: 18985357
[TBL] [Abstract][Full Text] [Related]
8. Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 8: Management of cerebrospinal fluid shunt infection.
Tamber MS; Klimo P; Mazzola CA; Flannery AM;
J Neurosurg Pediatr; 2014 Nov; 14 Suppl 1():60-71. PubMed ID: 25988784
[TBL] [Abstract][Full Text] [Related]
9. Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.
Simon TD; Kronman MP; Whitlock KB; Gove NE; Mayer-Hamblett N; Browd SR; Cochrane DD; Holubkov R; Kulkarni AV; Langley M; Limbrick DD; Luerssen TG; Oakes WJ; Riva-Cambrin J; Rozzelle C; Shannon C; Tamber M; Wellons JC; Whitehead WE; Kestle JRW
J Neurosurg Pediatr; 2018 Apr; 21(4):346-358. PubMed ID: 29393813
[TBL] [Abstract][Full Text] [Related]
10. Infections of central nervous system shunts.
Gardner P; Leipzig T; Phillips P
Med Clin North Am; 1985 Mar; 69(2):297-314. PubMed ID: 3990436
[TBL] [Abstract][Full Text] [Related]
11. Infection risk for Bactiseal Universal Shunts versus Chhabra shunts in Ugandan infants: a randomized controlled trial.
Mbabazi-Kabachelor E; Shah M; Vaughan KA; Mugamba J; Ssenyonga P; Onen J; Nalule E; Kapur K; Warf BC
J Neurosurg Pediatr; 2019 Jan; 23(3):397-406. PubMed ID: 30611153
[TBL] [Abstract][Full Text] [Related]
12. Role of endoscopic third ventriculostomy at infected cerebrospinal fluid shunt removal.
Shimizu T; Luciano MG; Fukuhara T
J Neurosurg Pediatr; 2012 Mar; 9(3):320-6. PubMed ID: 22380962
[TBL] [Abstract][Full Text] [Related]
13. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
[TBL] [Abstract][Full Text] [Related]
14. Conservative management of patients with cerebrospinal fluid shunt infections.
Brown EM; Edwards RJ; Pople IK
Neurosurgery; 2006 Apr; 58(4):657-65; discussion 657-65. PubMed ID: 16575329
[TBL] [Abstract][Full Text] [Related]
15. Management of shunt infections: a multicenter pilot study.
Kestle JR; Garton HJ; Whitehead WE; Drake JM; Kulkarni AV; Cochrane DD; Muszynski C; Walker ML
J Neurosurg; 2006 Sep; 105(3 Suppl):177-81. PubMed ID: 16970229
[TBL] [Abstract][Full Text] [Related]
16. Recurrent cerebrospinal fluid shunt infection and the efficacy of reusing infected ventricular entry sites.
Winston KR; Ho JT; Dolan SA
J Neurosurg Pediatr; 2013 Jun; 11(6):635-42. PubMed ID: 23601015
[TBL] [Abstract][Full Text] [Related]
17. Linezolid treatment of shunt-related cerebrospinal fluid infections in children.
Yilmaz A; Dalgic N; Müslüman M; Sancar M; Colak I; Aydin Y
J Neurosurg Pediatr; 2010 May; 5(5):443-8. PubMed ID: 20433254
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid shunt infections in children.
Ronan A; Hogg GG; Klug GL
Pediatr Infect Dis J; 1995 Sep; 14(9):782-6. PubMed ID: 8559628
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
Conen A; Walti LN; Merlo A; Fluckiger U; Battegay M; Trampuz A
Clin Infect Dis; 2008 Jul; 47(1):73-82. PubMed ID: 18484878
[TBL] [Abstract][Full Text] [Related]
20. Prevention and management of internal cerebrospinal fluid shunt infections.
Dawod J; Tager A; Darouiche RO; Al Mohajer M
J Hosp Infect; 2016 Aug; 93(4):323-8. PubMed ID: 27107616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
